Clinical trials
Tuberculosis trials in South Africa with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Cape Town | 12 |
| Johns Hopkins University | 4 |
| University of Stellenbosch | 3 |
| Boston University | 2 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| Massachusetts General Hospital | 2 |
| University of California, San Francisco | 2 |
| Arizona State University | 1 |
| Boston College | 1 |
| Boston Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 41 |
| Acquired Immunodeficiency Syndrome | 5 |
| Disease | 4 |
| HIV Infections | 4 |
| Tuberculosis, Pulmonary | 3 |
| Latent Tuberculosis | 2 |
| Asthma | 1 |
| Bronchiectasis | 1 |
| COVID-19 | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.